X-Ray Structures of Myc-Max and Mad-Max Recognizing DNA Molecular Bases of Regulation by Proto-Oncogenic Transcription Factors

X-ray structures of the basic/helix-loop-helix/leucine zipper (bHLHZ) domains of Myc-Max and Mad-Max heterodimers bound to their common DNA target (Enhancer or E box hexanucleotide, 5'-CACGTG-3') have been determined at 1.9 A and 2.0 A resolution, respectively. E box recognition by these two structurally similar transcription factor pairs determines whether a cell will divide and proliferate (Myc-Max) or differentiate and become quiescent (Mad-Max). Deregulation of Myc has been implicated in the development of many human cancers, including Burkitt's lymphoma, neuroblastomas, and small cell lung cancers. Both quasisymmetric heterodimers resemble the symmetric Max homodimer, albeit with marked structural differences in the coiled-coil leucine zipper regions that explain preferential homo- and heteromeric dimerization of these three evolutionarily related DNA-binding proteins. The Myc-Max heterodimer, but not its Mad-Max counterpart, dimerizes to form a bivalent heterotetramer, which explains how Myc can upregulate expression of genes with promoters bearing widely separated E boxes.

[1]  Bong-Gyoon Han,et al.  Structural basis of water-specific transport through the AQP1 water channel , 2001, Nature.

[2]  K. Struhl,et al.  The GCN4 basic region leucine zipper binds DNA as a dimer of uninterrupted α Helices: Crystal structure of the protein-DNA complex , 1992, Cell.

[3]  L. Chin,et al.  An amino-terminal domain of Mxi1 mediates anti-myc oncogenic activity and interacts with a homolog of the Yeast Transcriptional Repressor SIN3 , 1995, Cell.

[4]  S K Burley,et al.  Co-crystal structure of sterol regulatory element binding protein 1a at 2.3 A resolution. , 1998, Structure.

[5]  Stephen K. Burley,et al.  Recognition by Max of its cognate DNA through a dimeric b/HLH/Z domain , 1993, Nature.

[6]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Eilers.  Control of cell proliferation by Myc family genes. , 1999, Molecules and cells.

[8]  A. Zervos,et al.  Isolation and characterization of Nmi, a novel partner of Myc proteins. , 1996, Oncogene.

[9]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[10]  J. Moore,et al.  A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. , 1987, Oncogene research.

[11]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[12]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[13]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[14]  M. Cole,et al.  The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation , 1999, Oncogene.

[15]  J. Bishop,et al.  The MYC protein activates transcription of the alpha‐prothymosin gene. , 1991, The EMBO journal.

[16]  R. Eisenman,et al.  Mad-max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3 , 1995, Cell.

[17]  M. Carey,et al.  The Enhanceosome and Transcriptional Synergy , 1998, Cell.

[18]  L. Larsson,et al.  Analysis of the DNA-binding activities of Myc/Max/Mad network complexes during induced differentiation of U-937 monoblasts and F9 teratocarcinoma cells , 1997, Oncogene.

[19]  C. Pabo,et al.  Distinctive DNA conformation with enlarged major groove is found in Zn-finger-DNA and other protein-DNA complexes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Bishop,et al.  Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29 , 1978, Journal of virology.

[21]  Takashi Kumasaka,et al.  Mechanism of c-Myb–C/EBPβ Cooperation from Separated Sites on a Promoter , 2002, Cell.

[22]  C. Dang,et al.  Involvement of the 'leucine zipper' region in the oligomerization and transforming activity of human c-myc protein , 1989, Nature.

[23]  P. Leder,et al.  Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[24]  J. Trent,et al.  Chromosome localization in normal human cells and neuroblastomas of a gene related to c-myc , 1984, Nature.

[25]  R. Eisenman,et al.  Myc‐Max heterodimers activate a DEAD box gene and interact with multiple E box‐related sites in vivo. , 1996, The EMBO journal.

[26]  R. Eisenman,et al.  Transcriptional activities of the Myc and Max proteins in mammalian cells. , 1992, Current topics in microbiology and immunology.

[27]  E. Lander,et al.  Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Watson,et al.  Nucleotide sequence analysis of human c-myc locus, chicken homologue, and myelocytomatosis virus MC29 transforming gene reveals a highly conserved gene product. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Eisenman,et al.  The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. , 1994, Cold Spring Harbor symposia on quantitative biology.

[30]  R. Cardiff,et al.  Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes. , 1992, Oncogene.

[31]  M. Cole,et al.  The Essential Cofactor TRRAP Recruits the Histone Acetyltransferase hGCN5 to c-Myc , 2000, Molecular and Cellular Biology.

[32]  G. Carmichael,et al.  An alternative pathway for gene regulation by Myc , 1997, The EMBO journal.

[33]  P. S. Kim,et al.  X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. , 1991, Science.

[34]  Hongtao Zhang,et al.  BRCA1 binds c-Myc and inhibits its transcriptional and transforming activity in cells , 1998, Oncogene.

[35]  S Gaubatz,et al.  Transcriptional activation by Myc is under negative control by the transcription factor AP‐2. , 1995, The EMBO journal.

[36]  D. Liao,et al.  c-Myc in breast cancer. , 2000, Endocrine-related cancer.

[37]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[38]  W. Somers,et al.  1.9 Å crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling , 1997, The EMBO journal.

[39]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[40]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[41]  D Eisenberg,et al.  The structure of granulocyte-colony-stimulating factor and its relationship to other growth factors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  E A Merritt,et al.  Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.

[43]  T. Ceska,et al.  The crystal structure of an intact human Max-DNA complex: new insights into mechanisms of transcriptional control. , 1997, Structure.

[44]  R. Brent,et al.  Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites , 1993, Cell.

[45]  F. Alt,et al.  Transposition and amplification of oncogene-related sequences in human neuroblastomas , 1983, Cell.

[46]  R. Eisenman,et al.  Myc target genes. , 1997, Trends in biochemical sciences.

[47]  K. Zeller,et al.  Function of the c-Myc oncogenic transcription factor. , 1999, Experimental cell research.

[48]  Wen‐Ming Yang,et al.  Histone Deacetylases Associated with the mSin3 Corepressor Mediate Mad Transcriptional Repression , 1997, Cell.

[49]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[50]  Joël Janin,et al.  Specific versus non-specific contacts in protein crystals , 1997, Nature Structural Biology.

[51]  R. Eisenman,et al.  The Mad protein family links transcriptional repression to cell differentiation. , 1998, Cold Spring Harbor symposia on quantitative biology.

[52]  P. Sharp,et al.  Myc/Max and other helix-loop-helix/leucine zipper proteins bend DNA toward the minor groove. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[54]  C. Dang,et al.  Discrimination between related DNA sites by a single amino acid residue of Myc-related basic-helix-loop-helix proteins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[55]  John R. Yates,et al.  Tra1p Is a Component of the Yeast Ada·Spt Transcriptional Regulatory Complexes* , 1998, The Journal of Biological Chemistry.

[56]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[57]  A. Simm,et al.  Determination of copy number of c-Myc protein per cell by quantitative Western blotting. , 1999, Analytical biochemistry.

[58]  D. Stuart,et al.  The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding , 1994, Cell.

[59]  J. Gottesfeld,et al.  Rapid identification of key amino-acid-DNA contacts through combinatorial peptide synthesis. , 2000, Chemistry & biology.

[60]  T. Muir,et al.  CHEMICAL LIGATION OF CYSTEINE-CONTAINING PEPTIDES : SYNTHESIS OF A 22 KDA TETHERED DIMER OF HIV-1 PROTEASE , 1995 .

[61]  Ken Chen,et al.  Gene-target recognition among members of the Myc superfamily and implications for oncogenesis , 2000, Nature Genetics.

[62]  J. Battey,et al.  L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer , 1985, Nature.

[63]  G. Prendergast,et al.  Association of Myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation , 1991, Cell.

[64]  E. Prochownik,et al.  MYC oncogenes and human neoplastic disease , 1999, Oncogene.

[65]  Stuart L Schreiber,et al.  Histone Deacetylase Activity Is Required for Full Transcriptional Repression by mSin3A , 1997, Cell.

[66]  G. Prendergast,et al.  New Myc-interacting proteins: a second Myc network emerges , 1999, Oncogene.

[67]  C. Croce,et al.  Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[68]  L. Larsson,et al.  Expression of mad, mxi1, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. , 1994, Oncogene.

[69]  L. Stanton,et al.  Nucleotide sequence of cloned cDNA of human c-myc oncogene , 1983, Nature.